Pharma Capital
CompanyCurrent (p)Volume
Sarossa (SARS) 1.52 14,021,775
GlaxoSmithKline (GSK) 1599.00 8,663,452
Sareum Holdings (SAR) 0.88 7,662,975
ReNeuron Group (RENE) 2.23 4,285,282
Gunsynd (GUN) 0.04 4,078,629
Vectura (VEC) 140.00 3,864,089
AstraZeneca (AZN) 4688.00 2,686,997
Oxford Biomedica (OXB) 4.70 2,545,177
Taihua (TAIH) 1.38 2,381,129
GW Pharmaceuticals (GWP) 735.00 2,319,262
Indivior (INDV) 320.90 2,148,380
Motif Bio (MTFB) 40.25 2,135,756
Shire (SHP) 4626.50 1,749,271
Proteome Sciences (PRM) 5.03 1,344,211
Hikma Pharmaceuticals (HIK) 1905.00 1,025,757
Vernalis (VER) 20.50 950,816
Oxford Pharmascience Group (OXP) 1.85 904,926
BTG (BTG) 644.00 709,252
SkyePharma (SKP) 443.00 524,876
Premaitha Health (NIPT) 9.88 517,522
Allergy Therapeutics (AGY) 27.25 477,459
Mereo BioPharma (MPH) 302.50 411,336
OptiBiotix Health (OPTI) 72.75 389,341
Immupharma (IMM) 53.00 385,187
Amryt Pharma (AMYT) 22.00 360,907
Abcam (ABC) 838.00 297,424
ValiRx (VAL) 2.50 287,754
Scancell Holdings (SCLP) 13.13 269,433
SkinBioTherapeutics (SBTX) 12.25 266,319
Clinigen Group (CLIN) 840.50 256,152

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.